Fracturas patológicas: introducción

Weber, 2004, An Aproach to the management of the patient with metastatic bone disease, Instr Course Lect, 53, 663 Pugh, 1982, Biomechanics of pathological fractures, Clin Orthop, 169, 109, 10.1097/00003086-198209000-00014 Rougraff, 1998, Evaluation of the patient with carcinoma of unknown origin metastatic to bone, 621 Katzer, 2002, Surgery of skeletal metastases, Arch Orthop Trauma Surg, 122, 251, 10.1007/s00402-001-0359-2 Sim HM. Metastatic bone disease of the pelvis and femur. En: Eilert RE, editor. Instr Course Lect. 1992;41:317-27. Ward, 1995, Disseminated intravascular coagulopathy (DIC) complicating intramedullary fixation of impending femur fracture from metastatic prostate cancer, Orthopedics, 18, 1115, 10.3928/0147-7447-19951101-15 Lipton, 2005, Management of bone metastases in breast cancer, Curr Treat Options Oncol, 6, 161, 10.1007/s11864-005-0023-0 Frassica, 2003, General principles of external beam radiation for skeletal metastases, Clin Orthop Relat Res, 415, 158, 10.1097/01.blo.0000093057.96273.fb Rosen, 2004, Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial, Cancer, 100, 2613, 10.1002/cncr.20308 Hillner, 2000, American Society of Clinical Oncology guideline on the role of biphosphonates in breast cancer. American Society of Clinical Oncology Biphosphonates Expert Panel, J Clin Oncol, 18, 1378, 10.1200/JCO.2000.18.6.1378 Wardley, 2005, Zoledronic acid significantly improves pain score and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital biphosphonate administration, Br J Cancer, 92, 1869, 10.1038/sj.bjc.6602551 Alcalá-Santaella, 2005, Enclavado endomedular profiláctico en metástasis de los huesos largos, 101 Harrington, 1986, Impending pathological fractures for metastatic malignancy: evaluation and management, Instr Course Lect, 35, 357 Mirels, 1989, Metastatic disease in long bones. A proposed Scoryng System for diagnosis Impending Pathological Fractures, Clin Orthop, 249, 256, 10.1097/00003086-198912000-00027 Van der Linden, 2004, Comparative analysis of risk factors for pathologic fracture with femoral metastases, J Bone Joint Surg Br, 86, 566, 10.1302/0301-620X.86B4.14703 Menk, 1988, Metastasis size in pathologic femoral fractures, Act Orthop Scand, 59, 151, 10.1080/17453678809169697 Weber, 2003, Operative treatment of long bone metastases, Clin Orthop, 415, 276, 10.1097/01.blo.0000093850.72468.54 Frassica, 1992, Metastatic bone disease: general principles, patophysiology, evaluation and biopsy, Instr Course Lect, 41, 293 Barwood SA, Wilson JL, Molnar RR, Choong PF. The incidence of acute cardiorespiratory and vascular dysfunction following intramedullary nail fixation of femoral metastasis. Acta Orthop Scand. 200;71:147-52. van Doorn, 1994, Intramedullary fixation in impending femur fractures caused by tumor metastases, Ned Tijdschr Geneeskd, 138, 2101 Yazawa, 1990, Metastasic bone disease. A study of the surgical treatment of 166 pathological humeral and femoral fractures, Clin Orthop, 251, 213, 10.1097/00003086-199002000-00036